Cell Culture Dish Podcast
Latest Episodes
Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture
In this podcast, I spoke with John Ketz and Denis Kole about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up stra
Using End-to-End Integrated Solutions to meet the High Demand for Viral Vector GMP Manufacturing
In this podcast, I spoke with Hanna Lesch Ph.D., Chief Technology Officer at Exothera about viral vector manufacturing. We discussed current industry needs and challenges, scalability, end to end solu
Implementing Quality by Design for AAV Products
In this podcast, we talked with Parth Trivedi, Business Development Manager, Pall Corporation, about the importance of implementing a Quality by Design strategy for AAV product manufacturing and speci
Streamline the ADC Path to the Clinic with One-stop Drug Development and Critical Technology Advancements
In this podcast, I talked with Dr. Jimmy Li, CEO of WuXi XDC, a WuXi Biologics subsidiary. We discussed the reasons for the formation of WuXi XDC, which was established via a joint venture between WuX
The benefits of using a single-source for discovery, development and GMP manufacture of antibody drug conjugates and other novel bioconjugates
In this podcast, I talked with Dr. Jimmy Li, CEO of WuXi XDC, a WuXi Biologics subsidiary. We discussed the reasons for the formation of WuXi XDC, which was established via a joint venture between WuX
Increasing speed and efficiency of biotherapeutic drug development with stable pools
In this podcast, we talked with Dr. Alison Porter, Head of Expression System Sciences, Lonza, about the use of stable pool expression to reduce drug development timelines. Highlights included the impl
Addressing the increasing demand for single-use technologies and supply chain shortages with future proof systems
Phil Sanders talks about the increase in demand for single-use equipment and consumables and how this has led to supply chain shortages.
Implementing Adherent Cell Culture Technology for Cell Therapy Bioprocess
Several of the most promising candidates in the pipeline use mesenchymal stromal cells and pluripotent stem cells, both of which require an adherent substrate for native biological function. Thus, uti
Evolving Beyond the Status Quo with Next Generation Buffer Prep Solutions
In this podcast, we spoke with Chris Rombach, Vice President of Sales and Marketing at Asahi Kasei Bioprocess America about buffer prep and delivery systems. We discussed current pain points and how n
Integrated Freezing Solutions to Minimize Risk and Preserve Product Quality
Claire Jarmey-Swan, Global Product Manager, Pall Corporation talks about the evolution freeze thaw technologies and how these new methods can streamline the process, minimize loss and maintain the highest product quality.